open access

Vol 23, No 2 (2020)
Original articles
Published online: 2020-07-31
Submitted: 2020-05-08
Accepted: 2020-07-24
Get Citation

Kidney efficiency index quantitative parameter of a dynamic renal scintigraphy. II. usefulness in the diagnosis of obstructive nephropathy

Pawel Cichocki, Krzysztof Filipczak, Anna Plachcinska, Jacek Kusmierek
DOI: 10.5603/NMR.2020.0018
·
Nucl. Med. Rev 2020;23(2):78-82.

open access

Vol 23, No 2 (2020)
Original articles
Published online: 2020-07-31
Submitted: 2020-05-08
Accepted: 2020-07-24

Abstract

BACKGROUND: One of the main indications for DSN is a diagnosis of obstructive uro-/nephropathy. In standard practice, this study includes the assessment of sequential scintigraphic images, renographic curves and such quantitative parameters as TMAX, T1/2 and split function of each kidney (SF). Due to the relative nature of SF and limitations of diagnostic capabilities of TMAX and T1/2, DSN was expanded to include new quantitative parameters describing kidney function in absolute values. This study aims to evaluate the usefulness of kidney efficiency index (KEi) — new, in-house developed parameter proportional to the average clearance function of the kidney.

MATERIAL AND METHODS: The study included 156 people aged 18–84 (average 51) years. The first group, from which normative values of new parameters were determined, consisted of 20 healthy volunteers. The second group consisted of 136 patients selected retrospectively, based on archived scintigraphic data. “Normalcy rate” (percentage of normal results among selected 62 patients with a low likelihood of obstructive uro-/nephropathy) was used to evaluate the reliability of KEi. A comparative differential analysis of obstructive uro-/nephropathy, based on standard and new DSN parameters, was performed on selected 74 patients (92 kidneys) with single functioning kidney or bilateral obstructive uropathy, where SF is unreliable.

RESULTS: Normative values: KEi ≥ 8; Normalcy rate for KEi: 95%. In comparison with standard DSN evaluation, application of KEi changed the diagnosis in 1/3 of assessed kidneys (from uropathy to nephropathy in 27/92 kidneys and vice versa in 4 kidneys).

CONCLUSIONS: KEi enables reproducible, quantitative assessment of absolute kidney function without any modifications of the standard DSN protocol. Its values can be compared between independent studies (e.g. follow-up examinations). KEi
corrected the diagnosis of obstructive uro-/nephropathy in cases of single functioning kidney or bilateral obstructive uropathy.

Abstract

BACKGROUND: One of the main indications for DSN is a diagnosis of obstructive uro-/nephropathy. In standard practice, this study includes the assessment of sequential scintigraphic images, renographic curves and such quantitative parameters as TMAX, T1/2 and split function of each kidney (SF). Due to the relative nature of SF and limitations of diagnostic capabilities of TMAX and T1/2, DSN was expanded to include new quantitative parameters describing kidney function in absolute values. This study aims to evaluate the usefulness of kidney efficiency index (KEi) — new, in-house developed parameter proportional to the average clearance function of the kidney.

MATERIAL AND METHODS: The study included 156 people aged 18–84 (average 51) years. The first group, from which normative values of new parameters were determined, consisted of 20 healthy volunteers. The second group consisted of 136 patients selected retrospectively, based on archived scintigraphic data. “Normalcy rate” (percentage of normal results among selected 62 patients with a low likelihood of obstructive uro-/nephropathy) was used to evaluate the reliability of KEi. A comparative differential analysis of obstructive uro-/nephropathy, based on standard and new DSN parameters, was performed on selected 74 patients (92 kidneys) with single functioning kidney or bilateral obstructive uropathy, where SF is unreliable.

RESULTS: Normative values: KEi ≥ 8; Normalcy rate for KEi: 95%. In comparison with standard DSN evaluation, application of KEi changed the diagnosis in 1/3 of assessed kidneys (from uropathy to nephropathy in 27/92 kidneys and vice versa in 4 kidneys).

CONCLUSIONS: KEi enables reproducible, quantitative assessment of absolute kidney function without any modifications of the standard DSN protocol. Its values can be compared between independent studies (e.g. follow-up examinations). KEi
corrected the diagnosis of obstructive uro-/nephropathy in cases of single functioning kidney or bilateral obstructive uropathy.

Get Citation

Keywords

humans; kidney; radioisotope renography; radiopharmaceuticals; technetium Tc 99m-ethylenedicysteine

About this article
Title

Kidney efficiency index quantitative parameter of a dynamic renal scintigraphy. II. usefulness in the diagnosis of obstructive nephropathy

Journal

Nuclear Medicine Review

Issue

Vol 23, No 2 (2020)

Pages

78-82

Published online

2020-07-31

DOI

10.5603/NMR.2020.0018

Bibliographic record

Nucl. Med. Rev 2020;23(2):78-82.

Keywords

humans
kidney
radioisotope renography
radiopharmaceuticals
technetium Tc 99m-ethylenedicysteine

Authors

Pawel Cichocki
Krzysztof Filipczak
Anna Plachcinska
Jacek Kusmierek

References (15)
  1. Taylor AT, Brandon DC, de Palma D, et al. SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0. Semin Nucl Med. 2018; 48(4): 377–390.
  2. Durand E, Blaufox MD, Britton KE, et al. International Scientific Committee of Radionuclides in Nephrourology (ISCORN). International Scientific Committee of Radionuclides in Nephrourology (ISCORN) consensus on renal transit time measurements. Semin Nucl Med. 2008; 38(1): 82–102.
  3. Taylor A, Nally JV. Clinical applications of renal scintigraphy. AJR Am J Roentgenol. 1995; 164(1): 31–41.
  4. Piepsz A, Dobbeleir A, Erbsmann F. Measurement of separate kidney clearance by means of 99mTc-DTPA complex and a scintillation camera. European Journal of Nuclear Medicine. 1977; 2(3).
  5. Schlegel JU, Halikiopoulos HL, Prima R. Determination of filtration fraction using the gamma scintillation camera. J Urol. 1979; 122(4): 447–450.
  6. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982; 138(3): 565–570.
  7. Filipczak K, Cichocki P, Surma M, et al. Renal Clearance Function Index-a New Quantitative Parameter of a Dynamic Renal Scintigraphy. Eur J Nucl Med Mol Imaging. 2019; 46: 243–4.
  8. Filipczak K, Cichocki P, Kuśmierek J, et al. Kidney Efficiency Index - Quantitative Parameter of a Dynamic Renal Scintigraphy. I. Theory and Verification. Nucl Med Rev. 2020; 23(2).
  9. Surma MJ, Wiewiórka J, Szadkowska A, et al. Pharmacokinetic characteristics of 99mTc-Ethylene-l-dicysteine (99mTc-EC). Nucl Med Rev Cent East Eur. 1999; 2(1): 20–27.
  10. Surma MJ, Wiewióra J, Liniecki J. Usefulness of 99Tcm-N,N'-ethylene-1-dicysteine complex for dynamic kidney investigations. Nucl Med Commun. 1994; 15(8): 628–635.
  11. O'Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for investigating the dilated upper urinary tract. Radionuclides in Nephrourology Group. Consensus Committee on Diuresis Renography. J Nucl Med. 1996; 37(11): 1872–1876.
  12. Rutland MD. A comprehensive analysis of renal DTPA studies. I. Theory and normal values. Nucl Med Commun. 1985; 6(1): 11–20.
  13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. ; 3(1): 1–150.
  14. Levey A. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Annals of Internal Medicine. 1999; 130(6): 461.
  15. Dias AH, Pintão S, Almeida P, et al. Comparison of GFR calculation methods: MDRD and CKD-EPI vs. (99m)Tc-DTPA tracer clearance rates. Scand J Clin Lab Invest. 2013; 73(4): 334–338.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl